Woo Y J, Zhang J C, Vijayasarathy C, Zwacka R M, Englehardt J F, Gardner T J, Sweeney H L
Department of Surgery, School of Medicine, University of Pennsylvania, Philadelphia, USA.
Circulation. 1998 Nov 10;98(19 Suppl):II255-60; discussion II260-1.
Coronary revascularization entails obligatory myocardial ischemia followed by reperfusion with occasional resultant postischemic contractile dysfunction, a state associated with significant morbidity and mortality. This injury is attributed in part to oxygen free radicals and has been partially ameliorated with exogenous antioxidants, a strategy limited by agent instability, low titer, and inadequate cardiomyocyte uptake. Cardiac gene transfer with antioxidant encoding vectors may significantly enhance intracellular free radical scavenger activity.
C57/BL6 neonatal mice (age, 2 days; n = 131) underwent intrapericardial delivery of recombinant adenoviruses encoding superoxide dismutase (SOD) and catalase (Cat) (n = 76) or beta-galactosidase (LacZ) as a control (n = 55). After 3 days, hearts were explanted, and SOD and Cat transgene expression was detected by Western blot analysis. Spectrophotometric enzyme assays demonstrated enhanced SOD activity 1.6-fold (P < 0.0001) and Cat 3.6-fold (P < 0.00001) in experimental versus LacZ hearts. Isolated perfused hearts were subjected to 5 minutes of warm ischemia, and at 5, 10, and 15 minutes after initiation of reperfusion, LacZ controls lost 24%, 33%, and 41% of peak systolic apicobasal force, respectively, whereas experimental hearts lost 5%, 12%, and 20% (P < 0.001, each time point). In controls, rate of force generation diminished 8%, 17%, and 35%; in experimental hearts, it increased 1% at 5 minutes and decreased 5% and 15% and 10 and 15 minutes (P < 0.01, P < 0.05, P < 0.05). LacZ hearts exhibited dysfunction similar to hearts from uninjected animals (P = NS, each time point).
Adenovirus-mediated cardiac gene transfer and expression of SOD and Cat augment antioxidant enzyme activity and minimize contractile dysfunction after ischemic reperfusion in the isolated perfused neonatal mouse heart.
冠状动脉血运重建必然会导致心肌缺血,随后进行再灌注,偶尔会导致缺血后收缩功能障碍,这种状态与显著的发病率和死亡率相关。这种损伤部分归因于氧自由基,并且已通过外源性抗氧化剂得到部分改善,但该策略受到药物不稳定性、效价低和心肌细胞摄取不足的限制。用编码抗氧化剂的载体进行心脏基因转移可能会显著增强细胞内自由基清除剂的活性。
C57/BL6新生小鼠(年龄2天;n = 131)接受心包内注射编码超氧化物歧化酶(SOD)和过氧化氢酶(Cat)的重组腺病毒(n = 76)或作为对照的β-半乳糖苷酶(LacZ)(n = 55)。3天后,取出心脏,通过蛋白质印迹分析检测SOD和Cat转基因表达。分光光度酶法检测显示,与LacZ心脏相比,实验性心脏的SOD活性增强了1.6倍(P < 0.0001),Cat活性增强了3.6倍(P < 0.00001)。对离体灌注心脏进行5分钟的温缺血处理,在再灌注开始后的5、10和15分钟,LacZ对照组分别丧失了峰值收缩期心尖-心底力的24%、33%和41%,而实验性心脏分别丧失了5%、12%和20%(每个时间点P < 0.001)。在对照组中,力产生速率分别降低了8%、17%和35%;在实验性心脏中,5分钟时增加了1%,10和15分钟时分别降低了5%和15%(P < 0.01,P < 0.05,P < 0.05)。LacZ心脏表现出与未注射动物的心脏相似的功能障碍(每个时间点P = 无显著性差异)。
腺病毒介导的心脏基因转移以及SOD和Cat的表达增强了抗氧化酶活性,并使离体灌注新生小鼠心脏缺血再灌注后的收缩功能障碍最小化。